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Abstract
Background: Dietary n-3 and n-6 polyunsaturated fatty acids (PUFAs) have an impact on insulin secretion and
sensitivity but whether and how these may be related to maternal glucose homeostasis during pregnancy is
unclear.
Methods: Female Wistar rats (240–250 g) were assigned to laboratory CHOW or high fat diets rich in either n-6
(safflower oil; n-6 group) or n-6 + n-3 (safflower oil + fish oil; n-3 group) PUFAs. After 10 days half of the animals
in each diet group were inseminated and confirmed pregnant. An overnight fasted intravenous glucose tolerance
test (500 mg glucose/kg body weight) was performed on chronically cannulated non-pregnant and 20-day pregnant
rats. Indices of insulin secretion (β) and insulin sensitivity (S) were calculated from the plasma glucose and insulin
responses. The fatty acid composition of phospholipids was determined in samples of liver and two skeletal muscles
(soleus and red quadriceps).
Results: Pregnancy in the CHOW group significantly increased β (P < 0.001) and decreased S (P < 0.01). In contrast,
both n-6 and n-3 diets abolished both the pregnancy-induced decrease in S and pregnancy-induced increase in β
with the n-3 diet having a more potent effect on both S and β. S was positively correlated with the sum
of n-3 fatty acids, with docosahexaenoic acid (22:6 n-3) the major contributor, in liver (r = 0.485; P < 0.001),
red quadriceps (r = 0.421; P = 0.004) and soleus (r = 0.476; P < 0.001). In contrast S was inversely related to
arachidonic acid (20:4n-6) levels in liver and red quadriceps across all groups and these relationships were
particularly powerful in pregnancy (liver: r = -0.785; red quadriceps: r = -0.754, both P < 0.0001).
Conclusions: The results demonstrate potent effects of dietary fat amount and profile on glucoregulation
during pregnancy and emphasize the importance of the balance between dietary n-3 and n-6 PUFAs.
Keywords: Pregnancy, Dietary fat, Insulin sensitivity, Hyperinsulinemia
Abbreviations: AUC, Area under the curve; DHA, Docosahexanoic acid; GDM, Gestational diabetes;
IVGTT, Intravenous glucose tolerance test; PUFAs, Polyunsaturated fatty acids; S, Insulin sensitivity;
β, Insulin secretion
Background
Gestational diabetes mellitus (GDM) can be defined as
carbohydrate intolerance of varying severity with onset
or first recognition during pregnancy [1]. In addition to
increasing the risk of complications during pregnancy
and at delivery [2], women with a history of GDM are
more likely to develop type 2 diabetes in the future and
their offspring are also at a greater risk of developing
childhood obesity and other adverse metabolic outcomes
[3]. Precisely how pregnancy leads to GDM is still not
entirely clear. Normal pregnancy is characterized by a
progressive increase in insulin resistance, associated
with β-cell hyperplasia and a large increase in insulin
secretion, that leads to a transient state of glucose
intolerance [1]. Certain metabolic and hormonal
stresses during pregnancy, however, appear to create
an extreme manifestation of metabolic alternations
that results in GDM [4].
Dietary fat consumption, specifically the balance of
fatty acid subtypes, are likely to play a major role in
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optimal maternal and fetal health as there is an increas-
ing delivery of long-chain polyunsaturated fatty acids
(PUFAs) ramping up later in pregnancy to supply, inter
alia, docosahexanoic acid (22:6n-3; DHA) critical for
brain and nervous system development [5, 6]. These
PUFAs must come from the diet of the mother and their
amount and the n-3/n-6 balance may well be one of the
“stressors” that drives the pathogenesis of GDM [7, 8].
There is already a good deal of evidence from non-
pregnant humans and experimental animal models
showing that dietary fatty acid composition strongly in-
fluences both insulin secretion and sensitivity [9–11].
While the majority of the literature also support in-
creased saturated fat intake as an independent risk
factor for GDM or glucose intolerance during preg-
nancy [12–14], the role of long-chain PUFAs in the
context of glucose homeostasis of pregnant women is
less clear [13, 15]. Reliable consumption data on
PUFA subtypes (n-3 vs n-6) are scarce and the
materno-fetal transfer of n-3 PUFAs, especially DHA for
fetal development of the central nervous system, further
complicates the relationship between dietary intake,
bioavailability and effects on maternal glucoregulation.
We therefore aimed to investigate the effects of vary-
ing dietary total fat, and n-3 and n-6 PUFA intake on
intravenous glucose tolerance in pregnant rats using
derived measures of insulin secretion and systemic insu-
lin action, with a specific focus on fatty acid composition
in insulin-sensitive tissues a potential key variable under-




Female Wistar rats (12 weeks old at the beginning of the
study) were obtained from the Australian Animal
Resources Centre (Perth, Australia). All animals were
housed individually in the animal facility of the Univer-
sity of Wollongong and in a temperature-controlled
environment (22 °C) with a 12-h light/dark cycle.
Following 1 week of acclimatization, animals were ran-
domized into 3 diet groups (see below) with 2 subgroups
per diet, pregnant and non-pregnant. After receiving
their corresponding diets for 10 d, animals in the preg-
nant group were individually placed with a single sexu-
ally mature male rat for a period of 2–3 d, during which
they were checked at 12-h intervals for evidence of in-
semination (vaginal plug). The day on which a vaginal
plug was found was designated as day 1 of pregnancy.
This procedure resulted in 100 % successful insemin-
ation. After insemination, females returned to their indi-
vidual cages and their dietary treatment continued.
Cannulation was performed at day 15 of pregnancy for
pregnant rats and age-matched virgin rats as control.
Rats were anaesthetized with an intramuscular injec-
tion of 30 mg/kg body weight Rompun (xylazine) and
50 mg/kg body weight Ketamine. Cannulas were
inserted in the right and left jugular veins to infuse
glucose and withdraw blood during the intravenous
glucose tolerance test [16].
Diets
The 3 experimental diets were: a standard low fat/high
carbohydrate laboratory chow (5 % energy from fat from
a combination of lard, safflower and canola oils; Y.S.
Feeds, Young, Australia; CHOW), a low carbohydrate/
high n-6 PUFAs diet (59 % energy from fat, of which
100 % was safflower oil; n-6 group) and a low carbohy-
drate/high n-3 PUFAs diet (59 % energy from fat, of
which 30 % was fish oil (Max EPA, Scherer, Melbourne,
Australia) and 70 % was safflower oil; n-3 group). The
high fat diets were prepared in-house [17], made freshly
every 3–4 d and stored at 4 °C until use. Each animal
was given 310 kJ/day which was approximately their ad
libitum intake of laboratory chow at study entry to avoid
major changes in caloric intake and obesity. Spillage, if
any, was collected and additional diet of equal weight
was added to the next day’s intake. Overall, all rats were
observed to eat all the food provided over the course of
the experiment. Animals were fed on their respective
diets for a total of 5 weeks.
Intravenous glucose tolerance test (IVGTT)
At the end of 5 d post-cannulation (day 20 of pregnancy
for pregnant rats), rats were fasted overnight and
allowed at least 30 min acclimatization in testing cages
prior to the test. Immediately after taking a baseline
blood sample (400 μl), rats received an intravenous bolus
of 1 ml/kg body weight glucose (50 % w/v) over a 10-s
interval. Blood samples (200 μl) were taken at 2, 5, 10,
15 and 30 min and centrifuged at 12,000 × g for 1 min.
Plasma were stored at -20 °C for not more than one
month until assayed for glucose and insulin concentra-
tions. The remaining blood cells from the baseline and
10-min samples were pooled and re-suspended in 9 g/L
saline, 1 × 105 U/L heparin to a total volume of ~ 600 μl.
Re-suspended blood cells were infused into the animal
between the 15- and 30-min blood draws to maintain
body fluids and hematocrit levels. At the completion of
the IVGTT, rats were killed by an intravenous overdose
of Nembutal (120 mg/kg body weight). Samples of skel-
etal muscle and liver were snap frozen and stored at
-80 °C for subsequent analysis.
Biochemical analyses
Plasma glucose and insulin were measured in duplicates
using commercially available assay kits from Roche
(Mannheim, Germany) and EMD Millipore (St Charles,
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MO) respectively. The extraction and derivatization of
the fatty acids in muscle and liver phospholipids have
been described elsewhere [18, 19]. Briefly, tissue samples
were homogenized in 2:1 (v/v) chloroform: methanol
and total lipid extracts were isolated. Phospholipids and
triglycerides were then separated by solid phase extrac-
tion on Sep-pak silica cartridges (Waters, Milford, MA).
The phospholipid fraction was transmethylated with
140 g/L boron trifluoride (Sigma-Aldrich, St Louis, MO)
at 85 °C for 1 h. Methyl esters were extracted into hex-
ane. Following the removal of polar contaminants, the
methyl fatty acids were separated, identified and quanti-
tated by gas chromatography. The content of individual
fatty acids in the phospholipids was expressed as a
percentage of the total fatty acids. Liver triglycerides
were analyzed as above except the dried triglycerides
were re-dissolved in 200 μl of 95 % (v/v) ethanol. The
amount of triglycerides was determined using an enzym-
atic colorimetric test kit with a Cobas Mira® biochemis-
try analyzer (Roche Diagnostics, Sydney, Australia).
Insulin secretion and insulin sensitivity indices
The submaximal sensitivity of insulin secretion to glu-
cose (β) was calculated from the areas under the curves
(AUCs) of the plasma glucose and insulin responses to
the IVGTT as InsulinAUC0-30/GlucoseAUC0-30 [20]. An
index of insulin sensitivity (S) was obtained under the
assumption that the integrated responses (AUC) to an
IVGTT can be treated as a quasi-steady state and can
therefore be explained by a simple homeostatic model
assessment-like model [21]. Under the conditions tested
(fasting, glucose clamp, IVGTT) any two of glycemia,
the glucose-sensitivity of insulin secretion, and insulin




where G = glucose concentration, Rin = the rate of entry
of glucose into the system, β = the glucose-sensitivity of
insulin secretion, and S = the insulin sensitivity of
glucose disposal.
The index S was derived from this relationship as
1/(β* GlucoseAUC0-30) which, substituting for β
becomes 1/InsulinAUC0-30. In this study Rin is com-
posed of the known amount of exogenous glucose
delivered intravenously plus an unknown amount of
residual hepatic glucose output. As Rin was ignored in
the calculation of S assuming that the rate of entry
was constant across animals, the index will contain
any effects of treatments on endogenous glucose out-
put during IVGTT as well as effects on S. It will also
contain any effects of treatment on non-insulin
sensitive glucose disposal, which is omitted from the
model. The increased glucose uptake by the fetal-placental
unit will, to the extent that it is insulin-insensitive, lead to
overestimation of S during pregnancy. Using the glucose
turnover estimates obtained in pregnant rats by Nolan
and Proietto [22], and assuming that all of the additional
glucose uptake in pregnancy is insulin-insensitive, we cal-
culate that S will be overestimated in pregnancy by 20 %.
It should be noted that glucose uptake by the fetal-placen-
tal unit might be affected by litter size and total fetal
weight. However we did not note any effect of dietary
composition or fat content on litter size. This appears
to be consistent with the bulk of the relevant litera-
ture [23, 24]. This degree of overestimation due to
any fetal drain does not affect any conclusions drawn
from the analyses of S. The index β contains any ef-
fects of treatments on insulin clearance as well as ef-
fects on insulin secretion.
Statistical analyses
All summary data are presented as mean ± SEM. Effects
of pregnancy and diet were analyzed using two-way
ANOVA including an interaction term (Pregnancy*Diet)
with Bonferroni post hoc tests to compare group differ-
ences. Relationships between continuous variables were
analyzed using Pearson correlation. All analyses were
performed using JMP software (version 4.0.1, SAS, Cary,
NC) and GraphPad Prism Program (version 6.04, Graph-
Pad Software, San Diego, CA). Significance was accepted
at P value < 0.05.
Results
Body weight
All groups were matched for body weight at entry to the
study (Table 1). After 5 weeks of diet treatments, there
was the expected increase in body weight associated
with pregnancy across all diet groups (P < 0.001). Diet
also had an independent effect on body weight (P <
0.001) with animals in the n-6 group significantly heavier
(P < 0.05) than those in the CHOW group and no differ-
ence between the n-3 and n-6 groups (Table 1).
Glucose homeostasis
Fasting circulating levels of glucose and insulin did not
differ between diet groups in non-pregnant rats (Fig. 1a
and b). Consistent with the theory of a lower glucose
“set point” during pregnancy [22], chow-fed pregnant
rats had lower plasma glucose (4.14 ± 0.12 vs 5.78 ±
0.25 mmol/L for non-pregnant; P < 0.05) and higher
plasma insulin (280 ± 52 vs 161 ± 26 pmol/L for non-
pregnant; P = 0.07) concentrations. Pregnancy led to a
similar reduction in fasting glucose in the n-3 group (P
< 0.001; Fig. 1a) without altering the insulin level
(Fig. 1b). In contrast, pregnancy was without effect on
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fasting glucose in the n-6 group despite a significant
increase in insulin concentration (P < 0.05) comparable
to that in pregnant CHOW rats (Fig. 1b).
In response to IVGTT, pregnancy lowered the circulat-
ing glucose across all diet groups (P < 0.05) but both the
n-3 and n-6 diets negated the pregnancy-induced in-
crease in plasma insulin levels (Table 1). We derived the
insulin secretion (β) and insulin sensitivity (S) indices
from the IVGTT responses to gain further insights into
the dynamics of glucose homeostasis. Pregnancy induced
a 223 % increase in β (P < 0.001) and a 56 % reduction in
S (P < 0.01) in the CHOW group, effects that were com-
pletely abolished by either the n-3 or the n-6 diet (Fig. 2).
Rats fed with a diet high in n-3 PUFAs also had the
highest S among all pregnant groups (P < 0.01; Fig. 2b).
Correction for the estimated bias in S during pregnancy
reduced pregnant S by 20 % (see Methods) but had no
effects on this analysis (data not shown), thus preserving
the effect of both high fat diets on the response of S to
pregnancy.
Membrane lipid composition
The fatty acid compositions of red quadriceps and soleus
skeletal muscles and liver were profiled. In non-pregnant
rats, the high fat diets had the expected effects on
enriching the membrane lipids, with the proportion of
the corresponding PUFAs increased at the expense of
monounsaturated and/or other PUFAs whereas the
proportion of saturated fatty acids remained un-
changed (Fig. 3a). As a result, the n-3 group had a
higher total n-3/n-6 ratio, and vice versa for the n-6
group (fatty acid profiles of muscle and liver in indi-
vidual animal were included in Additional file 1:
Table S1).
Pregnancy had no major effects on the PUFAs in
muscle and liver in the CHOW group, except a
Fig. 1 Effects of pregnancy and diet on fasting plasma glucose (a)
and insulin (b) levels. N = 7–8 per group. *** P < 0.001 and * P < 0.05
compared to non-pregnant rats in the same diet group. ## P < 0.01
and # P < 0.05 compared to pregnant rats in the CHOW group.
CHOW, standard laboratory chow diet; N-3, high n-3 long-chain
polyunsaturated fatty acids diet; N-6, high n-6 long-chain
polyunsaturated fatty acids diet
Table 1 Body weight and biochemical analyses (N = 7–8 per group)
CHOW N-3 N-6 P-value
Non-pregnant Pregnant Non-pregnant Pregnant Non-pregnant Pregnant Pregnancy Diet Interaction
Before dietary interventions
Weight [g] 241 ± 3 242 ± 2 245 ± 3 242 ± 1 246 ± 3 246 ± 4 NS NS NS
After dietary interventions
Weight [g] 265 ± 3 303 ± 5 284 ± 2 319 ± 4 287 ± 3 319 ± 2 <0.001 < 0.001 NS
Fasting glucose [mmol/L] 5.78 ± 0.25 4.41 ± 0.12 6.54 ± 0.52 3.91 ± 0.33 6.83 ± 0.53 6.01 ± 0.34 < 0.001 < 0.01 NS
Fasting insulin [pmol/L] 161 ± 26 280 ± 52 189 ± 36 116 ± 19 162 ± 28 305 ± 45 < 0.05 NS < 0.01
IVGTT glucose AUC[min*
mmol/L]a
270 ± 20 183 ± 6 300 ± 23 219 ± 12 325 ± 18 260 ± 12 < 0.001 < 0.01 NS
IVGTT insulin AUC[min*
nmol/L]a
11.9 ± 1.4 27.2 ± 3.9 10.3 ± 0.7 9.4 ± 1.1 17.0 ± 2.7 18.9 ± 2.9 < 0.01 < 0.001 < 0.01
Liver triglycerides
[mmol/mg]
8.30 ± 0.69 7.79 ± 0.56 6.45 ± 0.89 6.13 ± 0.70 10.7 ± 0.89 8.31 ± 1.00 NS < 0.001 NS
aIVGTT intravenous glucose tolerance test, AUC area under the curve
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significant reduction in n-3 PUFAs (14.6 ± 0.5 vs 17.9 ±
0.2 % for non-pregnant; P < 0.001) and an almost recip-
rocal increase in n-6 PUFAs (41.3 ± 0.6 vs 38.0 ± 0.8 %
for non-pregnant; P < 0.001) in the soleus muscle. In rats
fed with a high n-3 PUFAs diet, however, pregnancy
induced tissue-specific changes in n-3 and n-6 PUFAs
content. While there were more n-3 PUFAs (26.0 ± 0.7
vs 16.7 ± 0.9 % for non-pregnant; P < 0.001) and less n-6
PUFAs (27.6 ± 0.3 vs 39.7 ± 1.3 % for non-pregnant; P <
0.001) in the liver compared to their non-pregnant
counterparts, the opposite trend (i.e., less n-3 PUFAs
and more n-6 PUFAs) was observed in both the red
quadriceps (P < 0.001) and soleus (P < 0.01; Fig. 3b).
Overall, fatty acid unsaturation index (number of double
bonds per fatty acid moiety) was significantly increased
in red quadriceps and soleus muscles and trended to be
elevated in the liver of pregnant rats fed with a high n-3
diet (P = 0.05). Despite a significant pregnancy-induced
increase in the proportion of n-6 PUFAs in the red
quadriceps (49.9 ± 0.6 vs 46.3 ± 2.1 % for non-pregnant;
P < 0.05) and soleus (53.1 ± 0.6 vs 48.9 ± 1.6 % for non-
pregnant; P < 0.01), membrane fatty acid profile of
skeletal muscle and liver, as well as the fatty acid
unsaturation index, in the n-6 group remained largely
stable irrespective of pregnancy status.
Relationships between membrane lipid composition and
insulin sensitivity
Across all rats, irrespective of diet and pregnancy status,
the proportion of n-3 PUFAs in the tissue phospholipid
was positively correlated with S (r = 0.485 for liver, P <
0.001; r = 0.421 for red quadriceps, P = 0.004; r = 0.476
for soleus, P < 0.001; Fig. 4a–c). In contrast, there was an
inverse relationship between the abundance of n-6
PUFAs in the membrane lipid with S (r = −0.411 for
liver, P = 0.0045; r = −0.345 for red quadriceps, P = 0.019;
r = −0.341 for soleus, P = 0.0202; Fig. 4d–f ). Correlation
statistics of individual treatment groups were summa-
rized in Table 2.
Next we examined the relationship between insulin
sensitivity and individual fatty acids to gain functional
insights. DHA made up to ~75–90 % of all n-3 PUFAs
in tissues and, as expected, it was the major contributor
to the overall n-3 PUFAs correlations (Table 2). With n-
6 PUFAs we focused on arachidonic acid (20:4n-6) and
its dietary precursor linoleic acid (18:2n-6), the two most
predominant n-6 PUFAs in membrane phospholipid.
The relationships between these two fatty acids and S
were specific to tissue and pregnancy status. In the liver
and red quadriceps of pregnant rats, arachidonic acid
was negatively related to S (r = −0.785 for liver, P <
0.0001; r = −0.754 for red quadriceps, P < 0.0001), but
the opposite was true for linoleic acid (r = 0.454 for liver,
P = 0.0295; r = 0.635 for red quadriceps, P = 0.0011).
Interestingly, none of these associations were observed
in non-pregnant rats.
Not surprisingly given the above the ratio 20:4n-6/
18:2n-6 (used as a composite index of overall delta-6
desaturase, elongase and delta-5 desaturase activity) was
also related to insulin sensitivity in pregnancy, where
the 20:4n-6/18:2n-6 ratios in the liver, red quadriceps
and soleus were highly, and inversely, correlated to S
(r = −0.695 for liver, P = 0.0002; r = −0.733 for red
quadriceps, P < 0.0001; r = −0.663 for soleus, P = 0.0006;
Fig. 5). Product-precursor relationships are often used to
index fatty acid desaturase and elongase activities but one
must cautious in pregnancy as fetal drain may skew the
analysis.
Liver triglycerides
In the non-pregnant rats, there was a very modest trend
for the n-3 diet to reduce (P = 0.29) and the n-6 diet to
increase (P = 0.11) liver triglycerides as compared to
Fig. 2 Effects of pregnancy and diet on glucose homeostasis in
response to an acute glucose challenge. Insulin secretion (β; a) and
insulin sensitivity (S; b) indices were calculated from the area under
the curves of plasma glucose and insulin concentrations during the
intravenous glucose tolerance test. N = 7–8 per group. *** P < 0.001
and ** P < 0.01 compared to non-pregnant rats in the same diet
group. ### P < 0.001 compared to pregnant rats in the CHOW group.
Diet abbreviations as per Fig. 1
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CHOW (Table 1). There was no effect of pregnancy on
liver triglycerides in any of the diet groups.
Discussion
Maternal glucose homeostasis during pregnancy is com-
plex. It is a mixture of both alterations in insulin secre-
tion and insulin action. The overall effect appears to be
aimed at ensuring nutrient supply to nurture the fetus
plus maternal defence against excessive demand, reflect-
ing the specifics of the drain particularly in glucose and
specific fatty acids (e.g. n-3 PUFAs) for nervous system
growth. The present study highlights the important role
that specific long-chain essential fatty acids can play in
these dynamics.
Pregnant rats on the chow diet showed the expected
reductions in glycemia and insulin sensitivity and in-
crease in the insulin secretion index compared to non-
pregnant chow-fed controls. Diets higher in fat but also
increased in either family of long-chain PUFAs had no
significant overall effect on insulin secretion and only
the n-6 diet resulted in a marginal decrease in insulin
sensitivity in non-pregnant rats compared to chow-fed
controls (see Fig. 2). In contrast both n-6 and n-3
enriched diets had major effects when the glucoregula-
tory system is perturbed by the metabolic stress of preg-
nancy. N-3-enriched diet acted to improve overall
glucose homeostasis in pregnancy. This is shown clearly
in basal insulin which is seen to be dramatically lowered
by n-3 fatty acids and in the insulin AUC to an IVGTT
which is markedly lowered with no deterioration in
glucose AUC. The calculated measures of insulin sensi-
tivity and secretion demonstrated a complete abrogation
of pregnancy-induced changes, maintaining values
essentially equal to non-pregnant rats. The effects of the
n-6-enriched diet were intermediary between chow and
n-3 with evidence, compared to chow controls, of some
insulin resistance in the non-pregnant rats but an im-
provement, again compared to the chow group, during
pregnancy.
The nature of the relationship between insulin hyper-
secretion and insulin resistance is not straightforward.
The traditional argument has been that hyperinsulinemia
Fig. 3 Effects of diet on membrane lipid composition in non-pregnant (a) and pregnant (b) rats. The abundance of fatty acid subtypes in tissue
phospholipid was quantified using gas chromatography and expressed as percentage of total fatty acids. N = 7–8 per group. RQ, red quadriceps
muscle; SOL, soleus muscle. Diet abbreviations as per Fig. 1
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Table 2 Correlations between tissue phospholipids and insulin sensitivity index
All rats Non-pregnant Pregnant
r P-value r P-value r P-value
Liver
Sum of n-3 polyunsaturated fatty acids 0.485 0.0006 0.463 0.0259 0.625 0.0014
Sum of n-6 polyunsaturated fatty acids −0.411 0.0045 −0.440 0.0357 −0.588 0.0032
Docosahexaenoic acid (22:6n-3) 0.454 0.0015 0.469 0.0241 0.628 0.0013
Arachidonic acid (20:4n-6) −0.305 0.0394 −0.335 0.1180 −0.785 < 0.0001
Linoleic acid (18:2n-6) 0.283 0.0562 0.072 0.7434 0.454 0.0295
Red quadriceps
Sum of n-3 polyunsaturated fatty acids 0.421 0.0036 0.357 0.0949 0.450 0.0314
Sum of n-6 polyunsaturated fatty acids −0.345 0.0190 −0.360 0.0912 −0.291 0.1785
Docosahexaenoic acid (22:6n-3) 0.417 0.0039 0.344 0.1085 0.459 0.0274
Arachidonic acid (20:4n-6) −0.532 0.0001 −0.284 0.1891 −0.754 < 0.0001
Linoleic acid (18:2n-6) 0.351 0.0168 −0.120 0.5851 0.635 0.0011
Soleus
Sum of n-3 polyunsaturated fatty acids 0.476 0.0008 0.464 0.0256 0.451 0.0309
Sum of n-6 polyunsaturated fatty acids −0.341 0.0202 −0.483 0.0195 −0.162 0.4611
Docosahexaenoic acid (22:6n-3) 0.468 0.0010 0.487 0.0183 0.410 0.0521
Arachidonic acid (20:4n-6) 0.476 0.0008 0.401 0.0640 0.451 0.0309
Linoleic acid (18:2n-6) 0.306 0.0386 −0.153 0.4850 0.662 0.0006
Fig. 4 Correlations between tissue phospholipid composition and insulin sensitivity. a-c: correlations between the abundance of n-3 polyunsaturated
fatty acids in liver (A), red quadriceps (b) and soleus (c) muscle with the insulin sensitivity index (S). d-f: correlations between the abundance of n-6
polyunsaturated fatty acids in liver (d), red quadriceps (e) and soleus (f) muscles with S. Rats from all diet and pregnancy groups were included in this
analyses. N = 47. RQ, red quadriceps muscle; SOL, soleus muscle
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is a reaction to, or consequence of, hyperglycemia with
the high levels of insulin then driving insulin resistance
and eventually on to the development of type 2 diabetes
[25]. However, this framework for interpreting the
etiology of type 2 diabetes has been reevaluated by a
number of groups who propose a primary hyperinsuline-
mia as the critical “lesion” which may trigger the dysme-
tabolic sequelae leading to type 2 diabetes. Thus it has
been well argued that this primary predisposition to
excess insulin secretion per se is both bad for β-cell
health and predisposes insulin resistance [26–30]. This
alternative view may be particularly germane to under-
standing the complex glucose and insulin dynamics of
pregnancy. Our data, and that of others, in both rodents
[22] and humans [31] suggest that early in pregnancy
relative hypoglycemia is evident even as insulin se-
creting capacity and β-cell proliferation are manifest.
Interestingly Holness et al. [32] showed that increased
dietary n-3 (on a saturated fat background) in preg-
nant rats reduced glucose-stimulated insulin secretion
in isolated islets. Taken together with our findings,
these results suggest that the β-cell enlargement and
attendant insulin secreting capacity earlier in preg-
nancy is not related, and certainly not reactive, to
control of hyperglycemia. It is not clear from either
human or experimental animal studies whether this
primary hyperinsulinemia of pregnancy is beneficial
(e.g. as a growth factor for fetal development or to
provide necessary capacity to meet the insulin resist-
ance of later pregnancy) or detrimental in term of, as
noted above, β-cell health and insulin action later in
pregnancy. This is a critical area for future work.
High fat diet feeding (n-6 and n-3) had the expected
effects on membrane lipid composition in the non-
pregnant animals, with increased n-3 long-chain PUFAs
and increased n-6 long-chain PUFAs in the n-3 and n-6
groups respectively. However, pregnancy provoked a
quite remarkably different effect on membrane lipid
composition between liver and muscle tissues in the n-3
group. In the liver, the main effects of pregnancy were
increased n-3 content and an approximately equivalent
decreased n-6 content in the n-3 group, the net effect
being reflected in a major increase in the n-3/n-6 ratio
from 0.46 ± 0.01 to 0.94 ± 0.02. This pattern is consistent
with earlier work by Childs et al. [33]. In contrast, preg-
nancy was associated with a consistent decrease in
skeletal muscle n-3 and an increase in n-6 content,
largely independent of dietary treatment. There is
significant fetal demand for n-3 fatty acids during preg-
nancy, particularly for nervous system development. It is
therefore interesting that, despite this, the liver avidly
sequesters even more n-3 fatty acids, a result consistent
with those of Cunnane and Armstrong [34] who have
previously shown a marked, steady increase in hepatic
Fig. 5 Correlations between arachidonic/linoleic acids (20:4n-6/18:2n-6) ratio of tissue phospholipid and insulin sensitivity in pregnant rats.
Correlations between the ratio of the abundance of arachidonic and linoleic acids in liver (a), red quadriceps (b) and soleus (c) muscles with the
insulin sensitivity index. Rats from all diet groups were included in this analyses. N = 23. RQ, red quadriceps muscle; SOL, soleus muscle
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phospholipid n-3 fatty acids during pregnancy, peaking
at partuition and declining to control levels by 9 days
post-partum.
The increased levels of n-3 PUFAs in the liver during
pregnancy in the n-3 diet group is in line with the func-
tion of the liver to distribute n-3 PUFAs in very-low-
density-lipoprotein particles to the growing fetus. During
pregnancy the fetus requires long-chain n-3 PUFAs,
particularly DHA, via the placenta especially for nervous
system development. Certainly in humans, during
pregnancy, and especially during the last trimester, se-
cretion of very-low-density-lipoprotein (triglycerides)
from the liver is markedly increased [35]. There is evi-
dence, at least in rats, of strong correlations between
liver phospholipid/triglyceride fatty acid composition
and plasma fatty acid profile [36]. The lack of increase in
liver n-3 PUFAs during pregnancy in the CHOW and n-6
diet groups may then suggest a relative dietary paucity of
n-3 fatty acids works against the ability of the liver to
deliver optimal n-3 fatty acids to the fetus.
Muscles are depleted of n-3 fatty acids, presumably to
support fetal demand. The reduction in n-3 levels in
phospholipid averaged approximately 16.5 % across both
muscles in the 3 diet groups. Based on our early work
[17] and that of others [37], this is likely to result in a
decrease in muscle insulin sensitivity and contribute
substantially to pregnancy-induced insulin resistance.
The positive, and highly significant relationships
between n-3 in phospholipid and insulin sensitivity in all
sampled tissues is consistent with this, and highly sup-
portive of the role of n-3 in insulin action. The inverse
relationships between insulin sensitivity and arachidonic
acid (20:4n-6) were not seen in non-pregnant rats, but
powerful with pregnancy (liver and red quadriceps r =
−0.785 and −0.754 respectively; both P < 0.0001). Supply
of DHA and arachidonic acid to the fetus is considered
important to development (see [6]) and is consistent
with the major pregnancy-induced increase in fatty acid
desaturase and elongase activity as seen in the present
results. These results are consistent with the work of
Childs et al. [33] who demonstrated an increase in delta-
6 desaturase (FADS2) gene expression during pregnancy
which they related to pregnancy-related hormonal
changes (particularly progesterone and estradiol). Over-
all this aspect of our results highlights the fine balance
between provision of arachidonic acid to the fetus, its
negative effect on insulin action (which may be a part of
diversion of nutrients to the fetus) and the relatively
pro-inflammatory effects of arachidonic 2-series metabo-
lites. Taken together these considerations strongly
emphasize the potentially critical balance of dietary n-3
and n-6 PUFAs intake during pregnancy.
We have previously reported an apparent protective
effect of PUFA consumption against the development of
glucose intolerance during pregnancy in a sample of
Chinese women [13]. Due to limitations in dietary meth-
odologies we were unable in that study to determine
whether this effect was related to n-3 or n-6 consump-
tion, since both were present in the major dietary source
of PUFAs in this population (soy oil). To the extent that
the present study in rats is comparable to the human
pregnant state, our results strongly favor the involve-
ment of n-3 fatty acids in this protective effect.
Finally, both high fat diets resulted in increased body
weight compared to the chow-fed controls independent
of pregnancy status. Thus under conditions of matched
caloric intake the animals were able to increase body
weight in response to increased dietary fat and to preg-
nancy alone. Pregnancy in humans has been associated
with reductions in free-living physical activity sufficient
to nearly account for the increased energy costs of preg-
nancy [38] as well as increased energy efficiency during
treadmill exercise [39]. Our results are consistent with
such increases in energetic efficiency.
The experimental diet model used here provides a
platform for further investigation of a number of critical
questions. First, is hyperinsulinemia early in pregnancy
positive or negative for the mother or the fetus? Using
the n-3 diet compared to the other two diets the effect
of reducing insulinemia, and not impairing glucoregula-
tion, on offspring pancreatic β-cell status at birth and
lifespan glucoregulation can be studied. Second, by shift-
ing diets during pregnancy insulinemia can be manipu-
lated over periods corresponding to first, second and
third trimesters of pregnancy to determine the effect on
maternal glucoregulatory “health” during the latter
phases of pregnancy including development of insulin
resistance. These results can then inform human trials.
Of equal importance in these studies will be the subse-
quent effects on offspring epigenetic markers, body
composition, pancreatic β-cell status and insulin secret-
ing capacity.
Conclusions
The present results demonstrate that the amount and
type of dietary fat has potent effects on insulin secre-
tion and sensitivity during pregnancy. N-3 fatty acid
incorporation into structural lipid in liver and muscle
positively relates to insulin sensitivity. The benefits of
high n-6 PUFA diets are less clear. The greater the
unsaturation/elongation of linoleic to arachidonic acid,
the greater the insulin resistance in pregnant rats,
emphasizing the need to focus on both dietary fat
amount and n-3/n-6 PUFA balance in pregnancy. The
experimental model described provides a platform to
investigate the critical issue of the role of hyperinsuli-
nemia in glucoregulation of both mothers during
pregnancy and subsequently in offspring.
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